These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15183454)

  • 21. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.
    Hu-Lieskovan S; Heidel JD; Bartlett DW; Davis ME; Triche TJ
    Cancer Res; 2005 Oct; 65(19):8984-92. PubMed ID: 16204072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells.
    Thompson AD; Teitell MA; Arvand A; Denny CT
    Oncogene; 1999 Sep; 18(40):5506-13. PubMed ID: 10523827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines.
    Rorie CJ; Weissman BE
    Cancer Res; 2004 Oct; 64(20):7288-95. PubMed ID: 15492248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
    Lessnick SL; Braun BS; Denny CT; May WA
    Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
    Kikuchi R; Murakami M; Sobue S; Iwasaki T; Hagiwara K; Takagi A; Kojima T; Asano H; Suzuki M; Banno Y; Nozawa Y; Murate T
    Oncogene; 2007 Mar; 26(12):1802-10. PubMed ID: 16964281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
    Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
    Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.
    Spahn L; Siligan C; Bachmaier R; Schmid JA; Aryee DN; Kovar H
    Oncogene; 2003 Oct; 22(44):6819-29. PubMed ID: 14534527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression.
    Dauphinot L; De Oliveira C; Melot T; Sevenet N; Thomas V; Weissman BE; Delattre O
    Oncogene; 2001 May; 20(25):3258-65. PubMed ID: 11423975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
    Peng W; Huang X; Yang D
    Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
    Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
    Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular detection of EWS-Ets fusion transcripts and their clinicopathologic significance in Ewing's sarcoma/peripheral primitive neuroectodermal tumor.
    Wang H; Zheng J; Wang YP; Yang Y; You JF
    Chin Med J (Engl); 2005 Aug; 118(16):1323-9. PubMed ID: 16157025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M; Okita H; Hata J; Umezawa A
    Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
    Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
    Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The possible role of EWS-Fli1 in evasion of senescence in Ewing family tumors.
    Matsunobu T; Tanaka K; Nakamura T; Nakatani F; Sakimura R; Hanada M; Li X; Okada T; Oda Y; Tsuneyoshi M; Iwamoto Y
    Cancer Res; 2006 Jan; 66(2):803-11. PubMed ID: 16424012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.